Literature DB >> 9926873

Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons.

F Centeno1, A Mora, J M Fuentes, G Soler, E Claro.   

Abstract

Primary cultures of cerebellar granule neurons, maintained in a serum-containing medium, underwent apoptosis when exposed to C2-ceramide, as assessed by mitochondrial reduction of MTT and intranucleosomal DNA fragmentation. After an 18 h exposure to 50 microM C2-ceramide, cell viability decreased by 25-40%. Addition of lithium together with C2-ceramide resulted in a partial protection of apoptosis, which was maximal at 5 mM lithium (37% protection). When lithium was added 5 h before the apoptotic stimulus the neuroprotective effect of the ion was clearly increased (66% protection). This effect was not due to intracellular inositol depletion or inhibition of NMDA receptors. Our data broaden the nature of apoptotic insults being reversed by lithium, stressing the neuroprotective effects of the ion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9926873     DOI: 10.1097/00001756-199812210-00036

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

Review 1.  Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

Review 2.  Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Authors:  Rosilla F Bachmann; Robert J Schloesser; Todd D Gould; Husseini K Manji
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

3.  Calcium-activated NO production plays a role in neuronal death induced by beta-bungarotoxin in primary cultures of cerebellar granular neurons.

Authors:  Wen-Pei Tseng; Shoei-Yn Lin-Shiau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-17       Impact factor: 3.000

Review 4.  Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

Review 5.  The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

Review 6.  Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.

Authors:  Xiaohua Li; Gautam N Bijur; Richard S Jope
Journal:  Bipolar Disord       Date:  2002-04       Impact factor: 6.744

7.  Lithium blocks ethanol-induced modulation of protein kinases in the developing brain.

Authors:  Goutam Chakraborty; Mitsuo Saito; Rui-Fen Mao; Ray Wang; Csaba Vadasz; Mariko Saito
Journal:  Biochem Biophys Res Commun       Date:  2008-01-09       Impact factor: 3.575

8.  Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor.

Authors:  Ling Song; Tong Zhou; Richard S Jope
Journal:  BMC Neurosci       Date:  2004-05-24       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.